481 related articles for article (PubMed ID: 29071521)
1. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
3. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
[TBL] [Abstract][Full Text] [Related]
4. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
5. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
[TBL] [Abstract][Full Text] [Related]
6. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
7. LGE-CMR-derived texture features reflect poor prognosis in hypertrophic cardiomyopathy patients with systolic dysfunction: preliminary results.
Cheng S; Fang M; Cui C; Chen X; Yin G; Prasad SK; Dong D; Tian J; Zhao S
Eur Radiol; 2018 Nov; 28(11):4615-4624. PubMed ID: 29728817
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
Axelsson Raja A; Farhad H; Valente AM; Couce JP; Jefferies JL; Bundgaard H; Zahka K; Lever H; Murphy AM; Ashley E; Day SM; Sherrid MV; Shi L; Bluemke DA; Canter CE; Colan SD; Ho CY
Circulation; 2018 Aug; 138(8):782-792. PubMed ID: 29622585
[TBL] [Abstract][Full Text] [Related]
9. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
Chimura M; Onishi T; Tsukishiro Y; Sawada T; Kiuchi K; Shimane A; Okajima K; Yamada S; Taniguchi Y; Yasaka Y; Kawai H
Heart; 2017 May; 103(9):679-686. PubMed ID: 27799316
[TBL] [Abstract][Full Text] [Related]
11. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
Mordi I; Bezerra H; Carrick D; Tzemos N
JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.
Chaowu Y; Shihua Z; Jian L; Li L; Wei F
Circ Heart Fail; 2013 Sep; 6(5):1013-20. PubMed ID: 23873474
[TBL] [Abstract][Full Text] [Related]
13. Correlation of left ventricular dyssynchrony on gated myocardial perfusion SPECT analysis with extent of late gadolinium enhancement on cardiac magnetic resonance imaging in hypertrophic cardiomyopathy.
Yuki H; Utsunomiya D; Shiraishi S; Takashio S; Sakamoto F; Tsuda N; Oda S; Kidoh M; Nakaura T; Tsujita K; Yamashita Y
Heart Vessels; 2018 Jun; 33(6):623-629. PubMed ID: 29230571
[TBL] [Abstract][Full Text] [Related]
14. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
[TBL] [Abstract][Full Text] [Related]
15. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
[TBL] [Abstract][Full Text] [Related]
16. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
17. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
[TBL] [Abstract][Full Text] [Related]
18. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic cardiomyopathy.
Hinojar R; Zamorano JL; Fernández-Méndez M; Esteban A; Plaza-Martin M; González-Gómez A; Carbonell A; Rincón LM; Nácher JJJ; Fernández-Golfín C
Int J Cardiovasc Imaging; 2019 Jun; 35(6):1055-1065. PubMed ID: 30706353
[TBL] [Abstract][Full Text] [Related]
20. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
